Logo Image
Business
Practice ManagementMalpractice ConsultHealth Law & Policy
Watch
Expert ConversationsShows & PodcastsNews & Analysis
Conferences
Conference ListingConference Previews Conference Recaps
Publications
Urology Times JournalEditorial Advisory BoardUrologists in Cancer CareSupplements and Featured PublicationsClinical Forums Recaps
More
CME/CE
Resources
Begin Your Journey: Tackling BurnoutSponsored MediaLive EventsInteractive ToolsJob BoardPartnersSponsored ResourcesTreatment Landscape Evolutions

Subscribe

  • Business
  • Watch
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Benign Conditions
  • Benign Prostatic Hyperplasia
  • Bladder Cancer
  • Female Urology
  • Genitourinary Cancers
  • Genomic Testing
  • Hormone Therapy
  • Kidney Cancer
  • Kidney Stones
    • Challenging Anatomy
  • Men's Health
  • Next-Generation Imaging
  • OAB and Incontinence
    • Voiding Dysfunction
  • Pediatrics
  • Prostate Cancer
    • Controveries in Urologic Cancer
    • Drug Therapy
  • Sexual Dysfunction
  • UTUC
  • Urologic Surgery
    • Cosmetic Surgery
Spotlight -
Peer Exchange|
Peers and Perspectives|
Case-Based Peer Perspectives|
Urology Times Journal
Advertisement

Stephen G. Weiss II, MD, FACS

Advertisement

Articles by Stephen G. Weiss II, MD, FACS

Urologist to ABU: ‘I relinquish my certificate’ over MOC (Letter)

ByStephen G. Weiss II, MD, FACS
July 1st 2015

Urologist Stephen G. Weiss II, MD, FACS, explains why he is voluntarily relinquishing his American Board of Urology certificate.

Advertisement

Latest Updated Articles

  • Urologist to ABU: ‘I relinquish my certificate’ over MOC (Letter)
    Urologist to ABU: ‘I relinquish my certificate’ over MOC (Letter)

    July 1st 2015



Advertisement
Advertisement

Trending on Urology Times

1

The Evolving Landscape of Minimally Invasive BPH Therapy

2

TURP, HoLEP, and the Future of Minimally Invasive BPH Therapy

3

FDA grants 510(k) clearance to SpaceOAR Flex Hydrogel for prostate radiotherapy

4

FDA grants priority review to perioperative durvalumab plus enfortumab vedotin in MIBC

5

One year of Inlexzo: Evolving care in BCG-unresponsive NMIBC

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Job Board
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contagion Live
  • CGT Live
  • Neurology Live
  • HCP Live
  • Oncology Live
  • Contemporary Pediatrics
  • Contemporary OBGYN
  • Urology Times
  • The Educated Patient
  • Patient Care Online
HCP Live Network
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us